|
US7951917B1
(en)
|
1997-05-02 |
2011-05-31 |
Genentech, Inc. |
Method for making multispecific antibodies having heteromultimeric and common components
|
|
EP0979281B1
(en)
|
1997-05-02 |
2005-07-20 |
Genentech, Inc. |
A method for making multispecific antibodies having heteromultimeric and common components
|
|
DE19819846B4
(de)
|
1998-05-05 |
2016-11-24 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Multivalente Antikörper-Konstrukte
|
|
US6737056B1
(en)
|
1999-01-15 |
2004-05-18 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
|
ATE346866T1
(de)
|
2001-09-14 |
2006-12-15 |
Affimed Therapeutics Ag |
Multimerische, einzelkettige, tandem-fv- antikörper
|
|
US8546543B2
(en)
|
2004-11-12 |
2013-10-01 |
Xencor, Inc. |
Fc variants that extend antibody half-life
|
|
KR101374454B1
(ko)
*
|
2005-03-31 |
2014-03-17 |
추가이 세이야쿠 가부시키가이샤 |
회합제어에 의한 폴리펩티드 제조방법
|
|
EP2522727A1
(en)
|
2006-03-23 |
2012-11-14 |
Tohoku University |
Highly functional bispecific antibody
|
|
EP2471816A1
(en)
|
2006-08-30 |
2012-07-04 |
Genentech, Inc. |
Multispecific antibodies
|
|
EP2158221B1
(en)
|
2007-06-21 |
2018-08-29 |
MacroGenics, Inc. |
Covalent diabodies and uses thereof
|
|
SG189730A1
(en)
|
2008-04-02 |
2013-05-31 |
Macrogenics Inc |
Her2/neu-specific antibodies and methods of using same
|
|
WO2010109924A1
(ja)
|
2009-03-25 |
2010-09-30 |
国立大学法人東北大学 |
Lh型二重特異性抗体
|
|
WO2011091435A2
(en)
*
|
2010-01-25 |
2011-07-28 |
Mount Sinai School Of Medicine |
Methods of treating liver disease
|
|
US20110206672A1
(en)
|
2010-02-25 |
2011-08-25 |
Melvyn Little |
Antigen-Binding Molecule And Uses Thereof
|
|
TWI622597B
(zh)
*
|
2011-03-28 |
2018-05-01 |
賽諾菲公司 |
具有交叉結合區定向之雙重可變區類抗體結合蛋白
|
|
JP6407726B2
(ja)
|
2012-03-01 |
2018-10-24 |
アムゲン リサーチ (ミュンヘン) ゲーエムベーハーAMGEN Research(Munich)GmbH |
長寿命ポリペプチド結合分子
|
|
SG10201704846VA
(en)
|
2012-03-14 |
2017-07-28 |
Regeneron Pharma |
Multispecific antigen-binding molecules and uses thereof
|
|
US9382329B2
(en)
|
2012-08-14 |
2016-07-05 |
Ibc Pharmaceuticals, Inc. |
Disease therapy by inducing immune response to Trop-2 expressing cells
|
|
EP2938637A2
(en)
*
|
2012-12-28 |
2015-11-04 |
AbbVie Inc. |
Multivalent binding protein compositions
|
|
US9458244B2
(en)
*
|
2012-12-28 |
2016-10-04 |
Abbvie Inc. |
Single chain multivalent binding protein compositions and methods
|
|
JO3519B1
(ar)
|
2013-01-25 |
2020-07-05 |
Amgen Inc |
تركيبات أجسام مضادة لأجل cdh19 و cd3
|
|
US20140322236A1
(en)
*
|
2013-03-15 |
2014-10-30 |
Sdix, Llc |
Anti-human adora2a antibodies
|
|
JP6693872B2
(ja)
|
2013-07-25 |
2020-05-13 |
シトムクス セラピューティクス,インコーポレイティド |
多重特異性抗体、多重特異性活性化可能抗体、及びそれらの使用方法
|
|
WO2015048272A1
(en)
|
2013-09-25 |
2015-04-02 |
Amgen Inc. |
V-c-fc-v-c antibody
|
|
EP3054971B1
(en)
|
2013-10-11 |
2021-03-10 |
The United States of America, represented by the Secretary, Department of Health and Human Services |
Epstein-barr virus vaccines
|
|
EP3092250A4
(en)
*
|
2014-01-08 |
2017-05-24 |
Moderna Therapeutics, Inc. |
Polynucleotides for the in vivo production of antibodies
|
|
WO2015173756A2
(en)
|
2014-05-16 |
2015-11-19 |
Pfizer Inc. |
Bispecific antibodies
|
|
US10647768B2
(en)
|
2014-05-29 |
2020-05-12 |
Macrogenics, Inc. |
Multi-chain polypeptide-containing tri-specific binding molecules
|
|
US9212225B1
(en)
|
2014-07-01 |
2015-12-15 |
Amphivena Therapeutics, Inc. |
Bispecific CD33 and CD3 binding proteins
|
|
MX2016017393A
(es)
|
2014-07-01 |
2017-09-05 |
Pfizer |
Diacuerpos heterodimericos biespecificos y sus usos.
|
|
CA2955947A1
(en)
|
2014-07-25 |
2016-01-28 |
Cytomx Therapeutics, Inc. |
Anti-cd3 antibodies, activatable anti-cd3 antibodies, multispecific anti-cd3 antibodies, multispecific activatable anti-cd3 antibodies, and methods of using the same
|
|
EP2982693A1
(en)
|
2014-08-07 |
2016-02-10 |
Affimed Therapeutics AG |
CD3 binding domain
|
|
EP3197916A2
(en)
|
2014-09-25 |
2017-08-02 |
Amgen Inc. |
Protease-activatable bispecific proteins
|
|
MX2017012805A
(es)
|
2015-04-07 |
2018-04-11 |
Genentech Inc |
Complejo de unión a antígenos con actividad agonista y métodos de uso.
|
|
ES2984656T3
(es)
|
2015-05-13 |
2024-10-30 |
Ablynx Nv |
Polipéptidos que reclutan linfocitos T en función de la reactividad a CD3
|
|
EP3310811B1
(en)
|
2015-06-16 |
2021-06-16 |
Genentech, Inc. |
Anti-cd3 antibodies and methods of use
|
|
CN105384825B
(zh)
*
|
2015-08-11 |
2018-06-01 |
南京传奇生物科技有限公司 |
一种基于单域抗体的双特异性嵌合抗原受体及其应用
|
|
CN108290958B
(zh)
|
2015-10-02 |
2021-12-28 |
豪夫迈·罗氏有限公司 |
多特异性抗体
|
|
EP3156417A1
(en)
|
2015-10-13 |
2017-04-19 |
Affimed GmbH |
Multivalent fv antibodies
|
|
ES2894304T3
(es)
*
|
2015-10-25 |
2022-02-14 |
Sanofi Sa |
Proteínas de unión triespecíficas y/o trivalentes para la prevención o tratamiento de infección por VIH
|
|
EP3443006B1
(en)
|
2016-04-13 |
2023-08-02 |
Sanofi |
Trispecific and/or trivalent binding proteins
|
|
WO2018075564A1
(en)
*
|
2016-10-17 |
2018-04-26 |
University Of Maryland, College Park |
Multispecific antibodies targeting human immunodeficiency virus and methods of using the same
|
|
WO2018158349A1
(en)
|
2017-02-28 |
2018-09-07 |
Affimed Gmbh |
Tandem diabody for cd16a-directed nk-cell engagement
|
|
KR20200014379A
(ko)
|
2017-06-05 |
2020-02-10 |
얀센 바이오테크 인코포레이티드 |
비대칭 ch2-ch3 영역 돌연변이를 갖는 조작된 다중특이성 항체 및 다른 다량체 단백질
|
|
CN111788225B
(zh)
|
2017-10-10 |
2025-02-18 |
赛诺菲 |
抗cd38抗体及与抗cd3和抗cd28抗体的组合
|
|
WO2019175368A1
(en)
|
2018-03-14 |
2019-09-19 |
Affimed Gmbh |
Bispecific egfr/cd16 antigen-binding protein
|
|
WO2019179627A1
(en)
*
|
2018-03-22 |
2019-09-26 |
Universität Stuttgart |
Multivalent binding molecules
|
|
CN112512566A
(zh)
|
2018-04-03 |
2021-03-16 |
赛诺菲 |
抗原性爱泼斯坦-巴尔病毒多肽
|
|
EP3774914A2
(en)
|
2018-04-13 |
2021-02-17 |
Affimed GmbH |
Nk cell engaging antibody fusion constructs
|
|
EA202091977A1
(ru)
|
2018-05-28 |
2021-02-09 |
Драгонфлай Терапьютикс, Инк. |
Мультиспецифические связывающие белки, которые связывают cd33, nkg2d и cd16, и способы применения
|
|
IL279063B2
(en)
*
|
2018-05-31 |
2026-05-01 |
Washington University St Louis |
Chimeric antigen receptor T cells for cancer treatment
|
|
JP7599205B2
(ja)
|
2018-06-01 |
2024-12-13 |
アンヘレス セラピューティクス インコーポレイテッド |
細胞療法のための多様な抗原結合ドメイン、新規プラットフォームおよびその他の強化
|
|
TWI856979B
(zh)
|
2018-10-09 |
2024-10-01 |
法商賽諾菲公司 |
三特異性抗cd38、抗cd28和抗cd3結合蛋白和用於治療病毒感染的使用方法
|
|
US12365722B2
(en)
|
2018-10-19 |
2025-07-22 |
University Of Maryland, College Park |
Multispecific antibodies targeting multiple epitopes on the HIV-1 envelope
|
|
EP4578507A3
(en)
*
|
2018-11-01 |
2025-11-12 |
Gracell Biotechnologies (Shanghai) Co., Ltd. |
Compositions and methods for t cell engineering
|
|
TW202104274A
(zh)
|
2019-04-09 |
2021-02-01 |
法商賽諾菲公司 |
用於治療hiv感染之三特異性及/或三價結合蛋白
|
|
US11613576B2
(en)
|
2019-04-09 |
2023-03-28 |
Sanofi |
Trispecific binding proteins, methods, and uses thereof
|
|
JP7664175B2
(ja)
|
2019-04-09 |
2025-04-17 |
サノフイ |
三重特異性結合性タンパク質、方法、およびその使用
|
|
GB201906685D0
(en)
|
2019-05-13 |
2019-06-26 |
Ultrahuman Six Ltd |
Activatable protein constructs and uses thereof
|
|
US20220396635A1
(en)
*
|
2019-09-25 |
2022-12-15 |
Universität Stuttgart |
Trivalent binding molecules
|
|
WO2021089748A2
(en)
|
2019-11-06 |
2021-05-14 |
Amgen Research (Munich) Gmbh |
Multitargeting antigen-binding molecules for use in proliferative diseases
|
|
EP4408892A4
(en)
|
2021-09-29 |
2025-11-19 |
Modex Therapeutics Inc |
Antigen-binding polypeptides, antigen-binding polypeptide complexes, and their methods of use in HIV
|
|
CN118317979A
(zh)
|
2021-09-29 |
2024-07-09 |
摩德斯医疗股份有限公司 |
抗原结合多肽、抗原结合多肽复合物及其使用方法
|
|
TW202330594A
(zh)
|
2021-09-29 |
2023-08-01 |
美商莫德斯醫療公司 |
抗原結合多肽、抗原結合多肽複合物及其使用方法
|
|
CN118613504A
(zh)
|
2021-12-17 |
2024-09-06 |
摩德斯医疗股份有限公司 |
含有tnfsf配体的细胞外结构域的抗原结合多肽复合物
|
|
CN119836434A
(zh)
|
2022-06-30 |
2025-04-15 |
摩德斯医疗股份有限公司 |
抗SARS-CoV-2抗原结合多肽、多肽复合物及其使用方法
|
|
AU2023301087A1
(en)
|
2022-06-30 |
2025-02-13 |
Modex Therapeutics, Inc. |
Anti-sars-cov-2 antigen binding polypeptides, polypeptide complexes and methods of use thereof
|